Technology cost versus benefits
This article was originally published in The Gray Sheet
Executive Summary
HHS task force charged with encouraging medical innovation should consider ways HHS "can document and measure the collective value to society of advances in healthcare, to ensure that the benefits of innovation are fully recognized and accounted for," The Value Group maintains in an 1Aug. 23 letter. Comprised of healthcare industry leaders, including AdvaMed, The Value Group released a report touting the benefits of new technology earlier this year (2"The Gray Sheet" Feb. 2, 2004, p. 3)...
You may also be interested in...
New Technology Benefits Quantified In Report Funded By Health Coalition
Medical technology advances from 1980-2000 helped prevent 470,000 deaths, 2.3 mil. disabilities and 206 mil. days spent in the hospital, according to a study released Jan. 28
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.